| Sep 10 |
Alimera Sciences Takes Legal Action Against ANI Pharmaceuticals to Enforce Merger Agreement
|
| Aug 9 |
Should You Invest on Alimera Sciences, Inc. (ALIM) Right Now?
|
| Aug 6 |
Alimera Sciences GAAP EPS of -$0.06, revenue of $27M
|
| Aug 6 |
Alimera Sciences (ALIM) Reports Q2 Loss, Tops Revenue Estimates
|
| Aug 6 |
Alimera Sciences: Q2 Earnings Snapshot
|
| Aug 6 |
Alimera Sciences Reports Second Quarter 2024 Results
|
| Jul 25 |
Investing in Alimera Sciences (NASDAQ:ALIM) a year ago would have delivered you a 68% gain
|
| Jul 16 |
Alimera Sciences: Cheap CVR Optionality
|
| Jun 27 |
Biotech Stock Roundup: ALNY Up on Study Success, ALIM on Merger News & Other Updates
|
| Jun 25 |
Alimera (ALIM) Rises on Merger Deal With ANI Pharmaceuticals
|
